Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment

Clinical trial NCT01170962 · COMPLETED

Trial details

NCT number: NCT01170962
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C Virus

Start date: 2010-08-01
Primary completion: 2012-06-01
Enrollment: 512

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.